1.
Development of SGLT1 and SGLT2 inhibitors
by Rieg, Timo
Diabetologia, 2018-08-22, Vol.61 (10), p.2079-2086
2.
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
by Ghezzi, Chiara
Diabetologia, 2018-08-22, Vol.61 (10), p.2087-2097
3.
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes...
by Bartnik, M
Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.72-77
4.
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia
by Fiorentino, Teresa Vanessa
The journal of clinical endocrinology and metabolism, 2017-11, Vol.102 (11), p.3979-3989
5.
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
by GASTALDELLI, A
Diabetologia, 2004, Vol.47 (1), p.31-39
6.
Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index
by Tura, Andrea
Diabetologia, 2018-02-26, Vol.61 (5), p.1135-1141
7.
GLUT2, glucose sensing and glucose homeostasis
by Thorens, Bernard
Diabetologia, 2014-11-25, Vol.58 (2), p.221-232
8.
Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults
by Satman, Ilhan
European journal of epidemiology, 2013-01-01, Vol.28 (2), p.169-180
9.
Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria
by Færch, Kristine
The journal of clinical endocrinology and metabolism, 2017-10-01, Vol.102 (10), p.3712-3721
10.
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study
by Soriguer, F
Diabetologia, 2011-10-11, Vol.55 (1), p.88-93
11.
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
by Vallon, Volker
Annual review of medicine, 2015-01-14, Vol.66 (1), p.255-270
12.
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type...
by Jensen, D. H
Diabetologia, 2012-01-29, Vol.55 (5), p.1406-1416
13.
No direct effect of SGLT2 activity on glucagon secretion
by Kuhre, Rune E
Diabetologia, 2019-03-22, Vol.62 (6), p.1011-1023
14.
Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts
by Alyass, Akram
Diabetologia, 2014-10-08, Vol.58 (1), p.87-97
15.
Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey
by Ziegler, Dan
Diabetologia, 2015-02-28, Vol.58 (5), p.1118-1128
16.
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics
by Tura, A
Diabetologia, 2009-10-30, Vol.53 (1), p.144-152
17.
Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes
by Steenberg, Vivi R
Diabetologia, 2015-11-05, Vol.59 (2), p.363-370
18.
Direct effect of GLP-1 infusion on endogenous glucose production in humans
by Seghieri, M
Diabetologia, 2012-10-12, Vol.56 (1), p.156-161
19.
Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice
by Caesar, Robert
Gut, 2012-12, Vol.61 (12), p.1701-1707
20.
Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance
by Deleskog, A
Diabetologia, 2012-03-17, Vol.55 (6), p.1668-1678
